Possible scenario
Open Atlas Adoption
45% Chance
The most likely path is broad research uptake without immediate clinical translation. Academic neuroscience groups, AI-biology startups, and public funders use the 1,000-microprotein atlas as a reference layer alongside Prima Mente’s Alzheimer’s cell atlas and the U.S.-Big Tech biology dataset.
Secondary impacts
- Healthcare +0.3%
- Technology +0.2%
Tickers
- RXRX+0.7%
Portfolio impact
S&P 500+0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.